All content for The Long Run with Luke Timmerman is the property of Timmerman Report and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
The Long Run with Luke Timmerman
1 hour 5 minutes 47 seconds
1 month ago
Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.
The Long Run with Luke Timmerman
Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.
